The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Global Metabolic Biomarker Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Metabolic Biomarker Testing market research.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Metabolic Biomarker Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker
- Danaher
- Waters Corporation
- Thermo Fisher Scientific
- Biocrates Life Sciences
- Human Metabolome Technologies
Segment by Technology
- Separation Techniques
- Detection Techniques
- Others
Segment by Application
- Drug Discovery
- Nutrigenomics
- Toxicology Testing
- Personalized Medicine
- Functional Genomics
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
The Metabolic Biomarker Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Technology and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Technology Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2018 VS 2022 VS 2029
1.2.2 Separation Techniques
1.2.3 Detection Techniques
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metabolic Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Biomarker Testing Market Perspective (2018-2029)
2.2 Metabolic Biomarker Testing Growth Trends by Region
2.2.1 Global Metabolic Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Metabolic Biomarker Testing Historic Market Size by Region (2018-2023)
2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Region (2024-2029)
2.3 Metabolic Biomarker Testing Market Dynamics
2.3.1 Metabolic Biomarker Testing Industry Trends
2.3.2 Metabolic Biomarker Testing Market Drivers
2.3.3 Metabolic Biomarker Testing Market Challenges
2.3.4 Metabolic Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Biomarker Testing Players by Revenue
3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2018-2023)
3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2018-2023)
3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
3.4 Global Metabolic Biomarker Testing Market Concentration Ratio
3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2022
3.5 Metabolic Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Metabolic Biomarker Testing Product Solution and Service
3.7 Date of Enter into Metabolic Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Biomarker Testing Breakdown Data by Technology
4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2018-2023)
4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029)
5 Metabolic Biomarker Testing Breakdown Data by Application
5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2018-2023)
5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Metabolic Biomarker Testing Market Size (2018-2029)
6.2 North America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Metabolic Biomarker Testing Market Size by Country (2018-2023)
6.4 North America Metabolic Biomarker Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolic Biomarker Testing Market Size (2018-2029)
7.2 Europe Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Metabolic Biomarker Testing Market Size by Country (2018-2023)
7.4 Europe Metabolic Biomarker Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2018-2029)
8.2 Asia-Pacific Metabolic Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolic Biomarker Testing Market Size (2018-2029)
9.2 Latin America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Metabolic Biomarker Testing Market Size by Country (2018-2023)
9.4 Latin America Metabolic Biomarker Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2018-2029)
10.2 Middle East & Africa Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Bruker
11.3.1 Bruker Company Detail
11.3.2 Bruker Business Overview
11.3.3 Bruker Metabolic Biomarker Testing Introduction
11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.3.5 Bruker Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Metabolic Biomarker Testing Introduction
11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Waters Corporation
11.5.1 Waters Corporation Company Detail
11.5.2 Waters Corporation Business Overview
11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.5.5 Waters Corporation Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Biocrates Life Sciences
11.7.1 Biocrates Life Sciences Company Detail
11.7.2 Biocrates Life Sciences Business Overview
11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.7.5 Biocrates Life Sciences Recent Development
11.8 Human Metabolome Technologies
11.8.1 Human Metabolome Technologies Company Detail
11.8.2 Human Metabolome Technologies Business Overview
11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
11.8.5 Human Metabolome Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
